These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


427 related items for PubMed ID: 6445735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM, Moellering RC.
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
    Chattopadhyay B, Hall I, Curnow SR.
    Curr Med Res Opin; 1983 Nov; 8(8):577-81. PubMed ID: 6653135
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN, Bollinger MR, Alivisatos MR.
    Clin Ther; 1986 Nov; 8(6):655-7. PubMed ID: 3098426
    [Abstract] [Full Text] [Related]

  • 10. Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin.
    Neu HC.
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():63-8. PubMed ID: 6296031
    [No Abstract] [Full Text] [Related]

  • 11. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
    Thabaut A, Durosoir JL, Saliou P.
    Infection; 1982 Feb; 10 Suppl 3():S249-56. PubMed ID: 7152690
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
    Barry AL, Thornsberry C, Jones RN, Gavan TL.
    Cleve Clin Q; 1980 Feb; 47(4):311-9. PubMed ID: 6451334
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.
    Phaneuf D, Neu HC.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.
    Coppens L, Klastersky J.
    Antimicrob Agents Chemother; 1979 Mar; 15(3):396-9. PubMed ID: 111610
    [Abstract] [Full Text] [Related]

  • 18. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC, Gavan TL, Gerlach EH, Jones RN, Barry AL, Thornsberry C.
    Am J Med Sci; 1977 Mar; 274(3):255-63. PubMed ID: 610415
    [Abstract] [Full Text] [Related]

  • 19. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H, Jehl F.
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [Abstract] [Full Text] [Related]

  • 20. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA, Westerdaal NA.
    Infection; 1982 Jun; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.